Metis Partners were appointed by French Duncan to market and sell the IP assets of CatalySystems.
CatalySystems was manufacturing a range of water decontamination systems, under the brand name, Gyrecat, since 2009. The Company had conducted extensive R&D, with its first patent granted in 2012. The Company undertook lab-scale and real-world pilot-scale studies to test the feasibility of a commercial-scale solution. The products were market-ready but the Company was pre-revenue.
IP Assets Sold
- Granted patents protecting the Gyrecat technology in UK & Australia
- Portfolio of trade secrets
- Extensive & transferable organizational knowledge
- Portfolio of registered trademarks with international coverage
- Website content & registered domains
Highlight of this IP Sale
Our IP discovery exercise led to us identify a number of critical IP assets which were not immediately evident, including a portfolio of trade secrets and an extensive bank of organizational knowledge, which enabled us to communicate this additional value in our marketing. We delivered an IP valuation at the instruction of our client, undertaken concurrently with the marketing process to assist in understanding the acceptability of offers received. We were able to secure a five-figure return from a buyer who found a strategic fit for this technology in their product offering and continues to offer this technology today.